Applications of flow cytometry to clinical microbiology
Open accessAbstract
SUMMARY: Classical microbiology techniques are relatively slow in comparison to other analytical techniques, in many cases due to the need to culture the microorganisms. Furthermore, classical approaches are difficult with unculturable microorganisms. More recently, the emergence of molecular biology techniques, particularly those on antibodies and nucleic acid probes combined with amplification techniques, has provided speediness and specificity to microbiological diagnosis. Flow cytometry (FCM) allows single- or multiple-microbe detection in clinical samples in an easy, reliable, and fast way. Microbes can be identified on the basis of their peculiar cytometric parameters or by means of certain fluorochromes that can be used either independently or bound to specific antibodies or oligonucleotides. FCM has permitted the development of quantitative procedures to assess antimicrobial susceptibility and drug cytotoxicity in a rapid, accurate, and highly reproducible way. Furthermore, this technique allows the monitoring of in vitro antimicrobial activity and of antimicrobial treatments ex vivo. The most outstanding contribution of FCM is the possibility of detecting the presence of heterogeneous populations with different responses to antimicrobial treatments. Despite these advantages, the application of FCM in clinical microbiology is not yet widespread, probably due to the lack of access to flow cytometers or the lack of knowledge about the potential of this technique. One of the goals of this review is to attempt to mitigate this latter circumstance. We are convinced that in the near future, the availability of commercial kits should increase the use of this technique in the clinical microbiology laboratory.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Flow cytometry can assess effects of antimicrobial agents on microbial cells, including changes in cell viability, membrane integrity, and metabolic activity.
“flow cytometry can be used to assess the effects of antimicrobial agents on microbial cells, including changes in cell viability, membrane integrity, and metabolic activity [82].”
From Methods for screening and evaluation of antimicrobial activity: A review of protocols, advantages, and limitations (2024) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 353 · Cited by 300
Research works printed but not linked: 22
- Alberghina, L., and D. Porro. 1993. Quantitative flow cytometry: analysis of protein distributions in budding yeast. A mini-review. Yeast 9:815-823.
- Carter, E. A., E. P. Frank, and P. A. Hunter. 1993. Cytometric evaluation of antifungal agents, p. 111-120. In D. Lloyd (ed.), Flow cytometry in microbiology. Springer-Verlag, London, United Kingdom.
- Davey, H. M., A. S. Kaprelyants, and D. B. Kell. 1993. Flow cytometry analysis using rhodamine 123 of Micrococcus luteus at low growth rate in chemostat culture, p. 83-89. In D. Lloyd (ed.), Flow cytometry in microbi- ology. Springer-Verlag, London, United Kingdom.
- Doern, G. V. 1995. Introduction. Diagnostic technologies in clinical micro- biology, p. 14-43. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 1st ed. ASM Press, Washington, D.C.
- In D. Lloyd (ed.), Flow cytometry. Springer-Verlag, London, United King- dom.
- In M. Al-Rubeai and A. N. Emery (ed.), Flow cytometry applica- tions in cell culture. Marcel Dekker, Inc, New York, N.Y.
- Embretson, J., M. Zupancic, J. Beneke, M. Till, S. Wolinsky, J. L. Ribas, A. Burke, and A. T. Haase. 1993. Analysis of human immunodeficiency virus- infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc. Natl. Acad. Sci. USA 90:357-361.
- In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical micro- biology, 1st ed. ASM Press, Washington, D.C.
- Freeman, C. D., D. P. Nicolau, P. P. Belleveau, and P. P. Nightingale. 1997. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J. Antimicrob. Chemother. 39:677-683. 102.
- Frelat, G., C. Laplace-Builhe, and D. Grunwald. 1989. Microbial analysis by flow cytometry: present and future, p. 256-279. In A. Yen (ed.), Flow cytometry: advanced research and clinical applications. CRC Press, Inc., Boca Raton, Fla. 104.
- Gervaix, A., D. West, L. M. Leoni, D. D. Richman, F. Wong-Staal, and J. Corbeil. 1997. A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc. Natl. Acad. Sci. USA 94:4653-4658. 114.
- Jepras, R. I., J. Carter, S. C. Pearson, F. E. Paul, and M. J. Wilkinson. 1995. Development of a robust flow cytometric assay for determining num- bers of viable bacteria. Appl. Environ. Microbiol. 61:2696-2701. 151.
- V. Conan (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md. 153.
- In M. R. Melamed, T. Lindmo, and M. L. Mendelsohn (ed.), Flow cytometry and sorting. Wiley-Liss, Inc., New York, N.Y. 181.
- In P. R. Murray, E. J. Baron, M. A. Pfaller, F. Tenover, and R. Yolken (ed.), Manual of clinical microbiology, 1st ed. ASM Press, Washington, D.C. 182. Li, Q. X., L. S. Young, G. Niedobitek, C. W. Dawson, M. Birkenbach, F. Wang, and A. B. Rickinson. 1992. Epstein-Barr virus infection and replica- tion in a human epithelial cell system. Nature 356:347-350. 183.
- Lloyd, D. (ed.). 1993. Flow cytometry: a technique waiting for microbiolo- gists, p. 1-10. In Flow cytometry in microbiology. Springer-Verlag, London, United Kingdom.
- Lloyd, D. 1993. Flow cytometry in microbiology. Springer-Verlag, London, United Kingdom. 187.
- Roisman, F. R., A. Castello, H. Fainboim, A. Morelli, and L. Fainboim. 1994. Hepatitis B virus antigens in peripheral blood mononuclear cells during the course of viral infection. Clin. Immunol. Immunopathol. 70:99- 103. 279. Rosa, D., S. Campagnoli, C. Moretto, E. Guenzi, L. Cousens, M. Chin, C. Dong, A. J. Weiner, J. Y. Lau, Q. L. Choo, D. Chien, P. Pileri, M. Houghton, and S. Abrignani. 1996. A quantitative test to estimate neutralizing anti- bodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc. Natl. Acad. Sci. USA 93:1759- 1763. 280. Rosenthal, K. S., C. M. Hodnichak, and J. L. Summers. 1987. Flow cyto- metric evaluation of anti-herpes drugs. Cytometry 8:392-395. 281. Rothe, G., and G. Valet. 1988. Phagocytosis, intracellular pH, and cell volume in the multifunctional analysis of granulocytes by flow cytometry. Cytometry 9:316-324. 282. Rubin, F. A., and S. W. Rothman. 1997. Extinction or revitalization: clinical microbiologists look to the future. ASM News 63:530-531. 283.
- Scillian, J. J., T. M. McHugh, M. P. Busch, M. Tam, M. J. Fulwyler, D. Y. Chien, and G. N. Vyas. 1989. Early detection of antibodies against rDNA- produced HIV proteins with a flow cytometric assay. Blood 73:2041-2048. 291. Shapiro, H. M. 1995. Practical flow cytometry, 3rd ed. Wiley-Liss, New York, N.Y. 292.
- In Z. Darzynkiewicz and H. Crissman (ed.), Flow cytometry. Academic Press, Ltd., London, United Kingdom. 306. Steen, H., and E. Boye. 1981. Growth of Escherichia coli studied by dual- parameter flow cytometry. J. Bacteriol. 145:1091-1094. 307. Stein, G. E. 1996. Pharmacokinetics and pharmacodynamics of newer fluo- roquinolones. Clin. Infect. Dis. 23(Suppl. 1):S19-S24. 308.
- Tapp, H., and G. Stotzky. 1997. Monitoring the insecticidal toxins from Bacillus thuringiensis in soil with flow cytometry. Can. J. Microbiol. 43:1074- 1078. 314. The, T. H., A. P. van den Berg, A. M. Vlieger, G. van de Giessen, and W. J. van der Son. 1992. Direct detection of cytomegalovirus in peripheral blood leukocytes-a review of the antigenemia assay and polymerase chain reac- tion. Transplantation 54:193-198. 315.
- Woods, G. L. 1992. Automation in clinical microbiology. Am. J. Clin. Pathol. 98:S22-S30. 340. Xu, C., W. Meikrantz, R. Schlegel, and R. Sager. 1995. The human papil- loma virus 16E6 gene sensitizes human mammary epithelial cells to apo- ptosis induced by DNA damage. Proc. Natl. Acad. Sci. USA 92:7829-7833. 341. Yang, D. W., Y. Ohta, S. Yamaguchi, Y. Tsukada, Y. Haraguchi, H. Hoshino, H. Amagai, and I. Kobayashi. 1996. Sulfated colominic acid: an antiviral agent that inhibits the human immunodeficiency virus type 1 in vitro. Antiviral Res. 31:95-104. 342. Yang, G., S. Garhwal, J. C. Olson, and G. N. Vyas. 1994. Flow cytometric immunodetection of human immunodeficiency virus type 1 proviral DNA by heminested PCR and digoxigenin-labeled probes. Clin. Diagn. Lab. Immunol. 1:26-31. 343. Yang, G., J. C. Olson, R. Pu, and G. N. Vyas. 1995. Flow cytometric detection of human immunodeficiency virus type 1 proviral DNA by the polymerase chain reaction incorporating digoxigenin-or fluorescein-la- beled dUTP. Cytometry 21:197-202. 344. Yang, G., P. P. Ulrich, R. A. Aiyer, B. D. Rawal, and G. N. Vyas. 1993. Detection of hepatitis B virus in plasma using flow cytometric analyses of polymerase chain reaction-amplified DNA incorporating digoxigenin-11- dUTP. Blood 81:1083-1088. 345.
- Authors
- Álvarez-Barrientos, A., Arroyo, J., Cantón, R., Nombela, C., & Sánchez-Pérez, M.
- Affiliations
- <!--label omitted: 1-->Departamento de Microbiologı́a II, Facultad de Farmacia,1
- Universidad Complutense de Madrid (ES)
- ORCID
- Arroyo, Javier
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2000-04
- Volume
- 13
- Issue
- 2
- Pages
- 167-195
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC100149
- OpenAlex
- W2096541181
- Cited by
- 300
- References
- 353
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 16 · 2023: 18 · 2022: 17 · 2021: 12 · 2020: 10 · 2019: 26 · 2018: 11 · 2017: 9 · 2016: 7 · 2015: 13 · 2014: 17 · 2013: 7 · 2012: 16
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
- Keywords
- flow cytometry, clinical microbiology, antimicrobial susceptibility testing, drug cytotoxicity, unculturable microorganisms, microbial detection, fluorescent dyes, antibody-based detection, oligonucleotide probes, bacterial heterogeneity, rapid diagnosis
- MeSH terms
- Flow Cytometry, Humans, Infections, Laboratories, Microbial Sensitivity Tests, Microbiological Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review